Ravi Rao Ph.D.

Ravi Rao, PhD, is a biotech entrepreneur. He has more than 20 years of experience in build companies and robust product portfolios. Most recently, Dr. Rao served as the CEO of TRex Bio, where he build a company aimed at discovering new therapies to restore tissue homeostasis. Prior to that, he served as the interim CEO of Complexa where he led the turnaround of the organization post Series C. Prior to Complexa, Dr. Rao was Chief Business Officer at Vtesse, where he was responsible for corporate strategy development and financial operations, which led to him being instrumental in the sale of the company to Sucampo Pharmaceuticals. Prior to joining Vtesse, he held increasing levels of responsibilities within corporate development and strategy consulting at Genocea Biosciences, MedImmune and Booz&Co (now Strategy&). Dr. Rao holds a BS in Biology and Chemistry from the University of Wisconsin at Superior and a PhD in Biochemistry and Molecular Biophysics from the University of Pennsylvania.